L. Damon

J. Radich, A. Logan, B. Wood, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Multicenter phase 1 trial of intraventricular immunochemotherapy in recurrent CNS lymphoma.

R. Advani, T. Batchelor, E. Gerstner, 2011, Blood.

Enhancement of 5-fluorouracil antitumor effects by the prior administration of methotrexate.

C. Benz, L. Damon, E. Cadman, 1989, Pharmacology & therapeutics.

Strickland, Eunice S. Wang, Kristina M. Gregory and Maoko Naganuma

M. Millenson, F. Appelbaum, D. Arber, 2013 .

Gallium‐avid thymic hyperplasia in an adult after chemotherapy for hodgkin disease

E. Small, A. Venook, L. Damon, 1993, Cancer.

Phase II study of high-dose [131I]metaiodobenzylguanidine therapy for patients with metastatic pheochromocytoma and paraganglioma.

R. Hawkins, K. Matthay, R. Goldsby, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Non-Hodgkin's lymphoma. Clinical practice guidelines in oncology.

M. Caligiuri, R. Advani, J. Vose, 2006, Journal of the National Comprehensive Cancer Network : JNCCN.

Non‐hodgkin's lymphomas

J. Byrd, R. Advani, J. Vose, 2010, Bone Marrow Transplantation.

High-dose cytarabine dose modification reduces the incidence of neurotoxicity in patients with renal insufficiency.

H. Rugo, L. Damon, H. Rugo, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Post-remission cytopenias following intense induction chemotherapy for acute myeloid leukemia.

H. Rugo, L. Damon, C. Ries, 1994, Leukemia.

Prevention and management of asparaginase/pegasparaginase-associated toxicities in adults and older adolescents: recommendations of an expert panel

A. Bleyer, G. Borthakur, W. Stock, 2011, Leukemia & lymphoma.

Intensified and shortened cyclical chemotherapy for adult acute lymphoblastic leukemia.

L. Damon, W. Navarro, C. Linker, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Malignant Pheochromocytomas and Paragangliomas

R. Hawkins, K. Matthay, R. Goldsby, 2006, Annals of the New York Academy of Sciences.

Long-term clinical outcomes of tisagenlecleucel in patients with relapsed or refractory aggressive B-cell lymphomas (JULIET): a multicentre, open-label, single-arm, phase 2 study.

M. Kersten, G. Salles, H. Holte, 2021, The Lancet. Oncology.

Efficacy of Venetoclax and Dexamethasone in Refractory IgM Primary Plasma Cell Leukemia with t(11;14) and TP53 Mutation: A Case Report and Literature Review

L. Damon, H. Abdulhaq, Salimah Valliani, 2020, Case reports in hematology.

High-dose chemotherapy (CTM) for breast cancer

H. Rugo, A. Zander, N. Cohen, 2000, Bone Marrow Transplantation.

Delayed engraftment of 4-hydroperoxycyclophosphamide-purged autologous bone marrow after induction treatment containing mitoxantrone for acute myelogenous leukemia.

L. Damon, H. Rugo, C. Ries, 1996, Bone marrow transplantation.

Granulocyte-macrophage colony-stimulating factor (GM-CSF)-secreting cellular immunotherapy in combination with autologous stem cell transplantation (ASCT) as postremission therapy for acute myeloid leukemia (AML).

W. Stock, D. DeAngelo, R. Stone, 2009, Blood.

Impact of intensive PBSC mobilization therapy on outcomes following auto-SCT for non-Hodgkin's lymphoma

L. Damon, K. Gaensler, J. Rubenstein, 2008, Bone Marrow Transplantation.

Cytoreduction of lymphoid malignancies and mobilization of blood hematopoietic progenitor cells with high doses of cyclophosphamide and etoposide plus filgrastim.

H. Rugo, S. Tolaney, L. Damon, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Impact of Plerixafor Use at Different Peripheral Blood CD34+ Thresholds on Autologous Stem Cell Collection in Patients with Multiple Myeloma.

A. Leavitt, L. Damon, T. Martin, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Rapid Improvement in Gemcitabine-associated Thrombotic Microangiopathy After a Single Dose of Eculizumab: Case Report and Review of the Literature

A. Ko, L. Damon, Z. Laszik, 2020, AntiCancer Research.

High-Dose Etoposide, Thiotepa, and Dose-Adjusted Carboplatin (TVCa) With Autologous Hematopoietic Stem Cell Rescue as Treatment of Relapsed or Refractory Germ Cell Cancer

H. Rugo, E. Small, L. Damon, 2005, American journal of clinical oncology.

The association between high-dose cytarabine neurotoxicity and renal insufficiency.

L. Damon, C. Linker, R. Mass, 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The use of ibrutinib in chronic lymphocytic leukemia.

L. Damon, 2016, Clinical advances in hematology & oncology : H&O.

Efficacy and Safety of Romiplostim in Patients with Low or Intermediate-Risk Myelodysplastic Syndrome (MDS) Receiving Decitabine.

P. Greenberg, H. Kantarjian, G. Garcia-Manero, 2009 .

A randomized controlled trial of romiplostim in patients with low- or intermediate-risk myelodysplastic syndrome receiving decitabine

P. Greenberg, A. Yang, G. Garcia-Manero, 2013, Leukemia & lymphoma.

Linfoma No Hodgkin

M. Caligiuri, A. Zelenetz, M. Czuczman, 2005 .

High-Dose Vincristine Sulfate Liposome Injection, for Advanced, Relapsed, or Refractory Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia in an Adolescent and Young Adult Subgroup of a Phase 2 Clinical Trial.

G. Schiller, S. Coutre, L. Damon, 2018, Journal of adolescent and young adult oncology.

Autologous stem cell transplantation for acute myeloid leukemia in first remission.

H. Rugo, L. Damon, P. Crilley, 2000, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Baboon Bone-Marrow Xenotransplant in a Patient with Advanced HIV Disease: Case Report and 8-Year Follow-Up

W. Heneine, P. Volberding, Phalguni Gupta, 2004, Transplantation.

Reductions in vancomycin and meropenem following the implementation of a febrile neutropenia management algorithm in hospitalized adults: An interrupted time series analysis

L. Damon, R. Rodriguez-Monguio, R. Olin, 2021, Infection Control & Hospital Epidemiology.

High-dose chemotherapy and hematopoietic stem cell rescue for breast cancer: experience in California.

J. Glaspy, L. Damon, D. Irwin, 2000, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

A randomized, controlled Phase III trial of therapeutic plasma exchange with fresh‐frozen plasma (FFP) prepared with amotosalen and ultraviolet A light compared to untreated FFP in thrombotic thrombocytopenic purpura

J. George, P. Mintz, C. Hillyer, 2006, Transfusion.

Thrombotic microangiopathies in the 1980s: clinical features, response to treatment, and the impact of the human immunodeficiency virus epidemic.

L. Damon, C. Ries, C. Linker, 1992, Blood.

Thrombosis associated with l‐asparaginase therapy and low fibrinogen levels in adult acute lymphoblastic leukemia

L. Damon, G. Beinart, 2004, American journal of hematology.

20q- clonality in a case of oral sweet syndrome and myelodysplasia.

K. Van Loon, R. Gill, L. Damon, 2012, American journal of clinical pathology.

Autologous bone marrow transplantation for acute myeloid leukemia using busulfan plus etoposide as a preparative regimen

H. Rugo, L. Damon, J. Wolf, 1993 .

Vincristine Sulfate Liposomes Injection (Marqibo®) Facilitates Durable Remissions and Potentially Curative Hematopoietic Stem Cell Transplantation in Adults with Advanced, Relapsed and/or Refractory Acute Lymphoblastic Leukemia

G. Schiller, S. Goldberg, L. Damon, 2011 .

Voriconazole is safe and effective as prophylaxis for early and late fungal infections following allogeneic hematopoietic stem cell transplantation

B. Guglielmo, L. Damon, L. Kaplan, 2010, Transplant infectious disease : an official journal of the Transplantation Society.

Autologous bone marrow transplantation for acute myeloid leukemia using busulfan plus etoposide as a preparative regimen.

H. Rugo, L. Damon, J. Wolf, 1993, Blood.

Acute myeloid leukemia ontogeny is defined by distinct somatic mutations.

D. Neuberg, B. Ebert, N. Lindeman, 2015, Blood.

Three prophylaxis regimens (tacrolimus, mycophenolate mofetil, and cyclophosphamide; tacrolimus, methotrexate, and bortezomib; or tacrolimus, methotrexate, and maraviroc) versus tacrolimus and methotrexate for prevention of graft-versus-host disease with haemopoietic cell transplantation with reduce

N. Geller, P. Hari, D. Porter, 2019, The Lancet. Haematology.

Phase III open-label randomized study of cytarabine in combination with amonafide L-malate or daunorubicin as induction therapy for patients with secondary acute myeloid leukemia.

P. Venugopal, D. Neuberg, M. Tallman, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Acute myeloid leukemia.

M. Millenson, F. Appelbaum, M. Tallman, 2008, Journal of the National Comprehensive Cancer Network : JNCCN.

Cytotoxicity of ketoconazole in malignant cell lines

C. Rochlitz, L. Damon, E. Cadman, 2004, Cancer Chemotherapy and Pharmacology.

Plasma and Cerebrospinal Fluid Pharmacokinetics of 1-β-d-Arabinofuranosylcytosine and 1-β-d-Arabinofuranosyluracil following the Repeated Intravenous Administration of High- and Intermediate-Dose 1-β-d-Arabinofuranosylcytosine

W. Plunkett, L. Damon, C. Linker, 1991 .

KIR and HLA Genotypes Predictive of Low-Affinity Interactions Are Associated with Lower Relapse in Autologous Hematopoietic Cell Transplantation for Acute Myeloid Leukemia

L. Damon, Jimmy Hwang, Juan Du, 2015, The Journal of Immunology.

Dual Targeting of Mesothelin and CD19 with Chimeric Antigen Receptor-Modified T Cells in Patients with Metastatic Pancreatic Cancer.

B. Levine, C. June, M. Tempero, 2020, Molecular therapy : the journal of the American Society of Gene Therapy.

Advances in rational combination chemotherapy.

L. Damon, E. Cadman, Lloyd E. Damon, 1986, Cancer investigation.

Unreliability of the abdominal fat pad biopsy in the evaluation of nephrosis: report of 3 consecutive cases.

J. Lipschutz, L. Damon, T. Yen, 1995, American journal of nephrology.

The metabolic basis for combination chemotherapy.

L. Damon, E. Cadman, Lloyd E. Damon, 1988, Pharmacology & therapeutics.

Plasma and Cerebrospinal Fluid Pharmacokinetics of 1-ÃŸ-D-Arabino-furanosy Icytosine and 1-ÃŸ-D-Arabinofuranosyluracil following the Repeated Intravenous Administration of High- and Intermediate-Dose l -ÃŸ-D-Arabinofuranosylcytosine1

W. Plunkett, L. Damon, C. Linker, 2006 .

Vosaroxin plus cytarabine versus placebo plus cytarabine in patients with first relapsed or refractory acute myeloid leukaemia (VALOR): a randomised, controlled, double-blind, multinational, phase 3 study.

Arnaud Pigneux, Gary Acton, Michael Heuser, 2015, The Lancet. Oncology.

Acute myeloid leukemia, version 2.2013.

M. Millenson, F. Appelbaum, K. Gregory, 2013, Journal of the National Comprehensive Cancer Network : JNCCN.

Acute myeloid leukemia clinical practice guidelines in oncology.

J. Byrd, E. Estey, M. Millenson, 2006, Journal of the National Comprehensive Cancer Network : JNCCN.

High-dose vincristine sulfate liposome injection for advanced, relapsed, and refractory adult Philadelphia chromosome-negative acute lymphoblastic leukemia.

Scott E. Smith, A. Nagler, H. Kantarjian, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A Case of Factitious Aplastic Anemia

L. Damon, S. Eisendrath, R. Bright, 2001, International journal of psychiatry in medicine.

Protein biomarker identification in the CSF of patients with CNS lymphoma.

Howard Schulman, Jane Fridlyand, J. Fridlyand, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Rituximab therapy for CNS lymphomas: targeting the leptomeningeal compartment.

K. Aldape, M. Shuman, L. Damon, 2003, Blood.

transplantation (ASCT) as postremission therapy for acute myeloid cellular immunotherapy in combination with autologous stem cell secreting - Granulocyte-macrophage colony-stimulating factor (GM-CSF)

D. DeAngelo, R. Stone, L. Damon, 2013 .

NCCN Clinical Practice Guidelines Acute myeloid leukemia.

M. Millenson, F. Appelbaum, K. Gregory, 2012, Journal of the National Comprehensive Cancer Network : JNCCN.

High CD34+ cell dose promotes faster platelet recovery after autologous stem cell transplantation for acute myeloid leukemia.

P. Varosy, L. Damon, W. Navarro, 2003, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Acute Myeloid Leukemia Hematopoietic Cell Transplantation for with Lower Relapse in Autologous Low-Affinity Interactions Are Associated Genotypes Predictive of HLA and KIR

L. Damon, Jimmy Hwang, Juan Du, 2015 .

Rituximab therapy for pure red cell aplasia due to anti-epoetin antibodies in a woman treated with epoetin-alfa: a case report

N. Terrault, L. Damon, C. Behler, 2009, Journal of medical case reports.

Graft-versus-host disease presenting with pancytopenia after en bloc multiorgan transplantation: case report and literature review.

L. Damon, R. Mawad, A. Hsieh, 2009, Transplantation proceedings.

Acute lymphoblastic leukemia, version 2.2015: Clinical practice guidelines in oncology

Patrick W. Burke, Andrew D. Zelenetz, Patricia Aoun, 2015 .

Ki67 and PIM1 expression predict outcome in mantle cell lymphoma treated with high dose therapy, stem cell transplantation and rituximab: a Cancer and Leukemia Group B 59909 correlative science study

B. Cheson, Sin-Ho Jung, R. Lai, 2008, Leukemia & lymphoma.

Detection of minimal residual disease following induction immunochemotherapy predicts progression free survival in mantle cell lymphoma: final results of CALGB 59909

B. Cheson, W. Stock, Hao Liu, 2012, Haematologica.

Immunochemotherapy and autologous stem-cell transplantation for untreated patients with mantle-cell lymphoma: CALGB 59909.

J. Byrd, A. LaCasce, B. Cheson, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Serial comprehensive geriatric and quality of life assessments in adults age ≥ 50 years undergoing autologous hematopoietic cell transplantation.

Chiung-Yu Huang, A. Logan, C. Andreadis, 2020, Journal of geriatric oncology.

A 75-year-old woman with thoracic spinal cord compression and chloroma (granulocytic sarcoma).

M. Tallman, G. Marcucci, L. Damon, 2012, Seminars in oncology.

Direct Oral Anticoagulant Use and Outcomes in Patients with High and Intermediate Risk BCR-ABL-Negative Myeloproliferative Neoplasms

A. Logan, A. Leavitt, Catherine C. Smith, 2019, Blood.

The Role of Endoscopic Evaluation in Patients with Suspected Intestinal Graft-Versus-Host Disease After Allogeneic Bone-Marrow Transplantation

H. Rugo, J. Terdiman, L. Damon, 1996, Endoscopy.

Hematopoietic cell transplantation comorbidity index (HCT-CI) is predictive of adverse events and overall survival in older allogeneic transplant recipients.

K. Gaensler, Catherine C. Smith, C. Andreadis, 2014, Journal of geriatric oncology.

Quantification of Acute Lymphoblastic Leukemia Clonotypes in Leukapheresed Peripheral Blood Progenitor Cells Predicts Relapse Risk after Autologous Hematopoietic Stem Cell Transplantation.

A. Logan, M. Faham, K. Kong, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Phase I study of intraventricular administration of rituximab in patients with recurrent CNS and intraocular lymphoma.

J. Fridlyand, M. Prados, J. O'Brien, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Immunochemotherapy with Intensive Consolidation for Primary CNS Lymphoma: A Pilot Study and Prognostic Assessment by Diffusion-Weighted MRI

J. O'Brien, S. Cha, M. Shuman, 2012, Clinical Cancer Research.

Histone Deacetylase Inhibition with Panobinostat Combined with Intensive Induction Chemotherapy in Older Patients with Acute Myeloid Leukemia: Phase I Study Results

A. Logan, P. Munster, C. Andreadis, 2019, Clinical Cancer Research.

Ofatumumab, Etoposide, and Cytarabine Intensive Mobilization Regimen in Patients with High-risk Relapsed/Refractory Diffuse Large B-Cell Lymphoma Undergoing Autologous Stem Cell Transplantation.

Chiung-Yu Huang, S. Kambhampati, C. Andreadis, 2020, Clinical lymphoma, myeloma & leukemia.

Auto-SCT for AML in second remission: CALGB Study 9620

K. Owzar, R. Larson, L. Damon, 2009, Bone Marrow Transplantation.

Patterns and predictors of functional decline after alloHCT in older adults.

Chiung-Yu Huang, A. Logan, K. Gaensler, 2022, Transplantation and cellular therapy.

Functional status as measured by geriatric assessment predicts inferior survival in older allogeneic hematopoietic cell transplant recipients.

Chiung-Yu Huang, A. Logan, K. Gaensler, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Inhibition of MET Signaling with Ficlatuzumab in Combination with Chemotherapy in Refractory AML: Clinical Outcomes and High-Dimensional Analysis.

V. Wang, D. Carbone, A. Logan, 2021, Blood cancer discovery.

Posttransplant Immunotherapy with a GM-CSF-Based Tumor Vaccine (GVAX®) Following Autologous Stem Cell Transplant (ASCT) for Acute Myeloid Leukemia (AML).

W. Stock, D. DeAngelo, L. Damon, 2004 .

Prognostic indicators and survival in patients with stage IIIB inflammatory breast carcinoma after dose-intense chemotherapy.

Y. Yen, J. Doroshow, L. Leong, 2004, Journal of Clinical Oncology.

A multicenter phase II study of darinaparsin in relapsed or refractory Hodgkin's and non‐Hodgkin's lymphoma

I. Lossos, M. Tallman, B. Schwartz, 2012, American journal of hematology.

Treatment of acute leukemia with idarubicin, etoposide and cytarabine (IDEA). A randomized study of etoposide schedule

H. Rugo, L. Damon, L. Johnston, 2004, Cancer Chemotherapy and Pharmacology.

Acute lymphoblastic leukemia.

A. Zelenetz, M. Millenson, O. Frankfurt, 2012, Journal of the National Comprehensive Cancer Network : JNCCN.

Delayed hematopoietic recovery after auto-SCT in patients receiving arsenic trioxide-based therapy for acute promyelocytic leukemia: a multi-center analysis

T. Naoe, A. Logan, A. Leavitt, 2015, Bone Marrow Transplantation.

Immuno-Chemotherapy (IC) and Autologous Stem Cell Transplant (ASCT) for Untreated Patients (pts) with Mantle Cell Lymphoma (MCL): CALGB 59909.

J. Byrd, B. Cheson, D. Niedzwiecki, 2006 .

Phase I/II Study of Bortezomib in Combination with Liposomal Doxorubicin and Melphalan in Relapsed or Refractory Multiple Myeloma.

A. Chari, L. Kaplan, L. Damon, 2005 .

Proteinuria in Metastatic Pheochromocytoma is Associated with an Increased Risk of Acute Respiratory Distress Syndrome, Spontaneously or After Therapy with 131I-Meta-iodobenzylguanidine (131I-MIBG)

K. Matthay, R. Goldsby, L. Damon, 2012, Hormone and Metabolic Research.

Anemias of chronic disease in the aged: diagnosis and treatment.

L. Damon, 1992, Geriatrics.

Pandemic (H1N1) 2009 Infection in Patients with Hematologic Malignancy

B. Schwartz, C. Chiu, Steve Miller, 2010, Emerging infectious diseases.

Busulfan plus etoposide as a preparative regimen for autologous bone marrow transplantation for acute myelogenous leukemia: an update.

H. Rugo, L. Damon, J. Wolf, 1993, Seminars in oncology.

A phase I study of targeted, dose-escalated intravenous busulfan in combination with etoposide as myeloablative therapy for autologous stem cell transplantation in acute myeloid leukemia.

L. Benet, A. Logan, K. Gaensler, 2015, Clinical lymphoma, myeloma & leukemia.

Limitation in Patient-Reported Function Is Associated with Inferior Survival in Older Adults Undergoing Autologous Hematopoietic Cell Transplantation.

Chiung-Yu Huang, A. Logan, C. Andreadis, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Progressive Neurological Impairment and an Enhancing Brainstem Lesion in a Middle-aged Man.

J. Gelfand, L. Damon, Sasha Gupta, 2019, JAMA Neurology.

Treatment of primary CNS lymphoma with induction high-dose methotrexate, temozolomide, rituximab followed by consolidation cytarabine/etoposide: A pilot study with biomarker analysis.

J. Fridlyand, K. Aldape, M. Prados, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

NCCN Guidelines Insights: Acute Lymphoblastic Leukemia, Version 1.2017.

O. Frankfurt, H. Kantarjian, K. Gregory, 2017, The Journal of the National Comprehensive Cancer Network.

ACCO: ASCO core curriculum outline.

J. V. Von Roenn, L. Deangelis, P. Harari, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Multigene Measurable Residual Disease Assessment Improves Acute Myeloid Leukemia Relapse Risk Stratification in Autologous Hematopoietic Cell Transplantation.

J. Radich, A. Logan, C. Hourigan, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Acute myeloid leukemia: Clinical Practice Guidelines in Oncology

M. Millenson, F. Appelbaum, K. Gregory, 2006 .

Phase 2B Randomized Study of CPX-351 Vs. Cytarabine (CYT) + Daunorubicin (DNR) (7+3 Regimen) In Newly Diagnosed AML Patients Aged 60–75

J. Cortes, M. Tallman, J. Lancet, 2010 .

Immunochemotherapy and autologous stem-cell transplantation for untreated patients with mantle-cell lymphoma: CALGB 59909.

J. Byrd, A. LaCasce, B. Cheson, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Eradication of Minimal Residual Disease during Treatment of Mantle Cell Lymphoma: CALGB 59909.

M. Caligiuri, B. Cheson, W. Stock, 2004 .

A randomized trial of high- vs standard-dose mitoxantrone with cytarabine in elderly patients with acute myeloid leukemia

H. Rugo, T. Ahmed, K. Seiter, 1997, Leukemia.

Multicenter phase 1 trial of intraventricular immunochemotherapy in recurrent CNS lymphoma.

R. Advani, T. Batchelor, E. Gerstner, 2011, Blood.

Evaluation of venous thromboembolism prophylaxis protocol in hematopoietic cell transplant patients

L. Damon, R. Olin, Melisa L. Wong, 2023, Bone Marrow Transplantation.